Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that controls hunger signals and blood sugar. The FDA-approved semaglutide formulation Ozempic begins at 0.25 mg weekly and typically increases to 1.0 mg or higher for weight management. Finding your effective dose requires personalized adjustment over 16 to 20 weeks, and PlexusDx offers compounded semaglutide injections that adapt to your body's unique response.

How Semaglutide Dosing Works for Weight Management

Semaglutide uses a step-up protocol rather than starting at a target dose. You begin with 0.25 mg injected under the skin once weekly, and your dose increases by 0.25 mg every four weeks if tolerated. This gradual approach allows your body to adapt to the medication while minimizing nausea and gastrointestinal side effects. Most people reach a maintenance dose between 1.0 mg and 2.4 mg weekly, though individual needs vary based on metabolism, body composition, and appetite response.

The dose escalation process typically spans four to five months before reaching a therapeutic level. Clinical trials show that participants using semaglutide lost between 5% and 22% of their body weight depending on the final dose achieved. Your healthcare provider monitors your weight loss progress, appetite suppression, and side effect tolerance at each adjustment to determine whether to continue increasing or hold at a current dose.

Typical Semaglutide Dose Ranges and Weight Loss Outcomes

Research indicates that doses of 0.5 mg to 1.0 mg weekly produce measurable appetite suppression and weight loss in most users. Higher doses between 1.5 mg and 2.4 mg may offer greater weight reduction but also increase the likelihood of side effects such as nausea, vomiting, or constipation. The relationship between dose and weight loss is not strictly linear—some individuals achieve significant results at lower doses due to individual genetic factors affecting GLP-1 receptor sensitivity and peptide pathway responsiveness.

A landmark clinical trial found that participants taking 2.4 mg semaglutide weekly lost an average of 14% to 15% of their baseline body weight over 68 weeks. However, doses as low as 0.5 mg weekly have demonstrated weight loss of 4% to 8% in certain populations. PlexusDx recognizes that dose optimization requires individualized assessment rather than a one-size-fits-all approach, which is why genetic testing through the Precision Peptide Genetic Test can inform your starting dose and trajectory.

Why Your Optimal Dose May Differ from Standard Ranges

Genetic variations influence how your body metabolizes semaglutide and responds to GLP-1 signaling. Variants in the GLP1R gene (such as rs6923761) affect receptor density and activation efficiency, meaning two people taking the same dose may experience very different appetite suppression and weight loss. Similarly, variations in the FTO gene (rs9939609) and MC4R gene (rs17782313) influence baseline appetite regulation and energy expenditure, creating natural differences in dose responsiveness.

Body composition, age, kidney function, and concurrent medications also shape your optimal semaglutide dose. Someone with a higher baseline metabolic rate or different fat distribution may require a different maintenance dose than predicted by body weight alone. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides relevant to GLP-1 therapy, helping identify whether your genetics predispose you toward faster or slower dose escalation, earlier side effects, or stronger appetite suppression at lower doses.

Personalized Dosing and Pricing at PlexusDx

PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies across all 50 states without requiring insurance or membership fees. Your dose may need to go up—your price won't. PlexusDx charges a flat monthly rate of $149 to $189 depending on your commitment tier, regardless of whether your healthcare provider adjusts your injection dose upward during the first four to five months of treatment.

After completing your first month of semaglutide therapy, PlexusDx offers the Precision Peptide Genetic Test as a $99 add-on. This peptide-pathway genetic test is distinct from pharmacogenomic testing and focuses on 150+ genetic insights across hunger, energy, and glucose regulation pathways. The test results inform your prescriber about whether your genetic profile suggests sensitivity to GLP-1 therapy at lower doses, predisposition to certain side effects, or the need for dose adjustments. HSA and FSA accounts are eligible for both medication and genetic testing at PlexusDx.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the starting dose of semaglutide for weight loss?

The starting dose is 0.25 mg injected subcutaneously once weekly. After four weeks, your dose increases by 0.25 mg weekly until reaching a therapeutic dose, typically between 1.0 mg and 2.4 mg. PlexusDx offers compounded semaglutide injections that follow this evidence-based escalation protocol, with flat pricing that does not increase as your dose adjusts upward.

How long does it take to reach an effective semaglutide dose?

Most people reach their target maintenance dose within 16 to 20 weeks of treatment. This gradual escalation approach allows your body to tolerate the medication and helps your healthcare provider identify the dose that provides the best balance between weight loss and side effect management. Throughout this period, PlexusDx maintains your flat monthly rate, so dose adjustments do not change your cost.

Does a higher semaglutide dose always mean greater weight loss?

Not necessarily. Clinical evidence shows a dose-response relationship, but individual factors including genetics, metabolism, and baseline body composition significantly influence outcomes. Some patients achieve substantial weight loss at 1.0 mg weekly, while others benefit from higher doses. This is why PlexusDx recommends the Precision Peptide Genetic Test to identify your genetic predispositions to GLP-1 responsiveness before finalizing your dosing strategy.

What are the common side effects at different semaglutide doses?

At lower doses (0.25–0.5 mg), side effects are typically mild. As doses increase, nausea, vomiting, constipation, and decreased appetite become more common. Most side effects diminish within days to weeks as your body adapts. If severe side effects persist, your healthcare provider may slow the dose escalation or adjust your maintenance dose downward. PlexusDx pharmacists and prescribers monitor your tolerance at every step.

Can genetic testing help predict my semaglutide dose needs?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 additional pathways influencing appetite and metabolism. These insights help your prescriber anticipate whether you may need dose adjustments sooner, experience certain side effects earlier, or achieve results at lower doses. The test costs $99 after your first month of semaglutide treatment.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves